To test the long term effect of a light treatment on cognition, sleep and metabolism in patients with Mild cognitive impairment (MCI) or mild Alzheimer's disease or related dementia (ADRD).
Mild Cognitive Impairment, Alzheimer Disease, Type2 Diabetes
To test the long term effect of a light treatment on cognition, sleep and metabolism in patients with Mild cognitive impairment (MCI) or mild Alzheimer's disease or related dementia (ADRD).
Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2
-
Rutgers University, New Brunswick, New Jersey, United States, 08854
Icahn School of Medicine at Mount Sinai, New York, New York, United States, 10029
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
55 Years to
ALL
No
Icahn School of Medicine at Mount Sinai,
Mariana G Figueiro, PhD, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai
2025-05-31